T2 Biosystems (NASDAQ:TTOO – Get Free Report) will announce its earnings results after the market closes on Monday, May 6th. Persons interested in participating in the company’s earnings conference call can do so using this link.
T2 Biosystems Stock Performance
T2 Biosystems stock opened at $3.72 on Friday. T2 Biosystems has a 12 month low of $2.60 and a 12 month high of $70.00. The stock’s 50 day simple moving average is $3.59 and its two-hundred day simple moving average is $4.41.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group dropped their price objective on shares of T2 Biosystems from $12.00 to $3.00 and set a “hold” rating on the stock in a research note on Monday, April 29th.
T2 Biosystems Company Profile
T2 Biosystems, Inc, an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
See Also
- Five stocks we like better than T2 Biosystems
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 4/29 – 5/3
- Roth IRA Calculator: Calculate Your Potential Returns
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
